Many risk factors for the development of severe forms of Covid-19 have been identified, some applying to the general population and others specific to Multiple Sclerosis (MS) patients. However, a score for quantifying the individual risk of severe Covid-19 in patients with MS is not available. The aim of this study was to construct such score and to evaluate its performance.

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis

Cocco, Eleonora;
2022-01-01

Abstract

Many risk factors for the development of severe forms of Covid-19 have been identified, some applying to the general population and others specific to Multiple Sclerosis (MS) patients. However, a score for quantifying the individual risk of severe Covid-19 in patients with MS is not available. The aim of this study was to construct such score and to evaluate its performance.
2022
Covid-19 severity
Multiple Sclerosis
Risk assessment score
Bayes Theorem
Humans
Male
Methylprednisolone
Personal Protective Equipment
COVID-19
Multiple Sclerosis
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2211034822004205-main.pdf

Solo gestori archivio

Tipologia: versione editoriale (VoR)
Dimensione 475.01 kB
Formato Adobe PDF
475.01 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/346860
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact